171 related articles for article (PubMed ID: 26581221)
1. Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei.
Wyllie S; Foth BJ; Kelner A; Sokolova AY; Berriman M; Fairlamb AH
J Antimicrob Chemother; 2016 Mar; 71(3):625-34. PubMed ID: 26581221
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6.
Baker N; Alsford S; Horn D
Mol Biochem Parasitol; 2011 Mar; 176(1):55-7. PubMed ID: 21093499
[TBL] [Abstract][Full Text] [Related]
3. Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activation.
Wyllie S; Patterson S; Fairlamb AH
Antimicrob Agents Chemother; 2013 Feb; 57(2):901-6. PubMed ID: 23208716
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.
Wilkinson SR; Taylor MC; Horn D; Kelly JM; Cheeseman I
Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5022-7. PubMed ID: 18367671
[TBL] [Abstract][Full Text] [Related]
5. Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis.
Sokolova AY; Wyllie S; Patterson S; Oza SL; Read KD; Fairlamb AH
Antimicrob Agents Chemother; 2010 Jul; 54(7):2893-900. PubMed ID: 20439607
[TBL] [Abstract][Full Text] [Related]
6. Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.
Wilkinson SR; Bot C; Kelly JM; Hall BS
Curr Top Med Chem; 2011; 11(16):2072-84. PubMed ID: 21619510
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole.
Prathalingham SR; Wilkinson SR; Horn D; Kelly JM
Antimicrob Agents Chemother; 2007 Feb; 51(2):755-8. PubMed ID: 17145786
[TBL] [Abstract][Full Text] [Related]
8. Gene expression study using real-time PCR identifies an NTR gene as a major marker of resistance to benzonidazole in Trypanosoma cruzi.
Mejía-Jaramillo AM; Fernández GJ; Palacio L; Triana-Chávez O
Parasit Vectors; 2011 Sep; 4():169. PubMed ID: 21892937
[TBL] [Abstract][Full Text] [Related]
9. Exploiting the drug-activating properties of a novel trypanosomal nitroreductase.
Hall BS; Wu X; Hu L; Wilkinson SR
Antimicrob Agents Chemother; 2010 Mar; 54(3):1193-9. PubMed ID: 20028822
[TBL] [Abstract][Full Text] [Related]
10. Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.
Hall BS; Meredith EL; Wilkinson SR
Antimicrob Agents Chemother; 2012 Nov; 56(11):5821-30. PubMed ID: 22948871
[TBL] [Abstract][Full Text] [Related]
11. Antiparasitic prodrug nifurtimox: revisiting its activation mechanism.
Cerecetto H; González M
Future Microbiol; 2011 Aug; 6(8):847-50. PubMed ID: 21861617
[TBL] [Abstract][Full Text] [Related]
12. Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert.
Campos MC; Leon LL; Taylor MC; Kelly JM
Mol Biochem Parasitol; 2014 Jan; 193(1):17-9. PubMed ID: 24462750
[TBL] [Abstract][Full Text] [Related]
13. Pentacyclic nitrofurans that rapidly kill nifurtimox-resistant trypanosomes.
Bruhn DF; Wyllie S; Rodríguez-Cortés A; Carrillo AK; Rakesh ; Guy RK; Fairlamb AH; Lee RE
J Antimicrob Chemother; 2016 Apr; 71(4):956-63. PubMed ID: 26682963
[TBL] [Abstract][Full Text] [Related]
14. Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites.
Hall BS; Bot C; Wilkinson SR
J Biol Chem; 2011 Apr; 286(15):13088-95. PubMed ID: 21345801
[TBL] [Abstract][Full Text] [Related]
15. New antiprotozoal agents: their synthesis and biological evaluations.
Upadhayaya RS; Dixit SS; Földesi A; Chattopadhyaya J
Bioorg Med Chem Lett; 2013 May; 23(9):2750-8. PubMed ID: 23518280
[TBL] [Abstract][Full Text] [Related]
16. Evaluating 5-nitrofurans as trypanocidal agents.
Bot C; Hall BS; Alvarez G; Di Maio R; González M; Cerecetto H; Wilkinson SR
Antimicrob Agents Chemother; 2013 Apr; 57(4):1638-47. PubMed ID: 23335745
[TBL] [Abstract][Full Text] [Related]
17. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
[TBL] [Abstract][Full Text] [Related]
18. Fexinidazole induced cytotoxicity is distinct from related anti-trypanosome nitroaromatic drugs.
Rogers I; Berg K; Ramirez H; Hovel-Miner GA
bioRxiv; 2023 Oct; ():. PubMed ID: 37873123
[TBL] [Abstract][Full Text] [Related]
19. Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania.
Wyllie S; Roberts AJ; Norval S; Patterson S; Foth BJ; Berriman M; Read KD; Fairlamb AH
PLoS Pathog; 2016 Nov; 12(11):e1005971. PubMed ID: 27812217
[TBL] [Abstract][Full Text] [Related]
20. Forward Genetics in African Trypanosomes.
Hutchinson S; Glover L
Methods Mol Biol; 2020; 2116():339-352. PubMed ID: 32221930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
